Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fondation Francophone pour la Recherche sur le Diabete | OTHER |
Not provided
Not provided
Not provided
Not provided
The worse prognosis observed in patients with Diabetic Foot Ulcer (DFU) has not been fully understood. Poor prognosis may be related to other conditions (inflammation, infectious disease, cancers) further to cardiovascular disease.
The aim of the study is to conduct the first prospective, observational and multi-centre cohort of patients with DFU in France, in order to evaluate the 5-years mortality rate, its causes and relevant prognostic determinants.
Diabetic foot ulcer (DFU) is one of the major complications frequently observed in patients with diabetes. DFU is the leading cause of non-traumatic lower-limb amputation (LLA), and it is associated with cognitive decline, worsening quality of life and substantial economic impact on French healthcare system. DFU is also associated with excess risk of premature death with significant decrease in life expectancy despite major improvement in medical care during last decades. The hypothesis of the study is that this worse prognosis seen in DFU patients may not be fully explained by a high cardiovascular risk, but mainly linked to different causes, including inflammatory, infectious and malignant conditions.
In addition, to conduct the first prospective, observational and multi-centre cohort of patients with DFU in France to evaluate the 5-years mortality rate, its causes and relevant prognostic determinants, the investigators will also assess all changes in health-related quality of life (HRQoL), and the economic impact related to DFU (cost of illness study) for the French healthcare system, using SNDS claims databases. A 3-year inclusion period will start during 2020, and each participant will be followed for 5 years or until death.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| DFU risk score | Construct a DFU risk score equation of all-death will be computed to determine individuals with the higher risk of worse outcomes. | 5 years after inclusion |
| Measure | Description | Time Frame |
|---|---|---|
| Survival without active index DFU | At 3 and 12 months after inclusion day | |
| Survival without recurrent index DFU | At 12, 24, 36, 48, 60 months after inclusion day | |
Not provided
Inclusion Criteria:
Adults with diabetes and DFU, defined as a foot skin ulceration or open LLA wound, measuring at least 5 mm of diameter, located below the malleolus, and induced by diabetic complications. In the case of an amputation before inclusion, the amputation stump will be considered as the main wound and not the wound that led to the amputation.
Exclusion Criteria:
Not provided
Not provided
Not provided
PDF study is designed to be the first French multicentre, observational and prospective cohort of patients with DFU referred from the community into secondary and tertiary care foot clinics.
Twenty-three French centres agreed to participate in this study. Each centre will recruit during the 3-year inclusion period.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Kamel MOHAMMEDI, Pr | Contact | 5 57 65 60 78 | +33 | kamel.mohammedi@chu-bordeaux.fr |
| Vincent RIGALLEAU, Pr | Contact | +33 | vincent.rigalleau@chu-bordeaux.fr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Côte de Nacre | Recruiting | Caen | France |
Not provided
Not provided
Not provided
Not provided
1 PAXgene blood DNA tube (2.5 mL)
| Survival without major adverse limb events (MALE) |
MALE is a composite of foot infection, non-traumatic lower-limb amputation (LLA), requirement of revascularization, whichever comes first. These components will be also considered individually. |
| 5 years after inclusion |
| Survival without major macrovascular events (MACE) | MACE is a composite of non-fatal myocardial infarction, non-fatal stroke, hospitalization for heart failure, or cardiovascular death, whichever comes first. | 5 years after inclusion |
| Survival without major microvascular events (MICE) | MICE is a composite of new-onset persistent macroalbuminuria, sustained 40% declined eGFR from baseline, ESRD, severe diabetic retinopathy or macular oedema requiring laser photocoagulation or intravitreal therapies, or diabetes-related blindness in either eye, whichever comes first. | 5 years after inclusion |
| CH Sud Francilien | Recruiting | Corbeil-Essonnes | France |
|
| CHU de Bocage Sud | Recruiting | Dijon | France |
|
| CHU de La Réunion - Site Sud | Recruiting | La Réunion | France |
|
| Groupe Hospitalier de La Rochelle Ré Aunis | Recruiting | La Rochelle | France |
|
| Hôtel Dieu | Not yet recruiting | Le Creusot | France |
|
| CHRU de Lille - Hôpital Claude Huriez | Recruiting | Lille | France |
|
| AP - HM - Hôpital de la Conception | Recruiting | Marseille | France |
|
| CHU de Montpellier - Hôpital Lapeyronie | Recruiting | Montpellier | France |
|
| CHU de Nantes Hôpital Nord Laennec | Recruiting | Nantes | France |
|
| CH Pierre Bérégovoy | Recruiting | Nevers | France |
|
| CHU de Nice - Hôpital l'Archet 2 | Recruiting | Nice | France |
|
| CHU Nîmes - Hôpital universitaire Carémeau | Not yet recruiting | Nîmes | France |
|
| AP-HP - Hôpital Bichat | Recruiting | Paris | France |
|
| AP-HP - Hôpital Lariboisière | Recruiting | Paris | France |
|
| AP-HP - Hôpital Pitié-Salpétrière | Recruiting | Paris | France |
|
| Hôpital Paris Saint Joseph | Recruiting | Paris | France |
|
| Hopital Haut-Leveque | Recruiting | Pessac | 33600 | France |
|
| HCL - Hôpital Lyon sud | Recruiting | Pierre-Bénite | France |
|
| CHU de la Milétrie | Recruiting | Poitiers | 86021 | France |
|
| CHU de Rouen | Recruiting | Rouen | France |
|
| Centre Hospitalier Saint Benoit | Recruiting | Saint-Benoît | 97470 | France |
|
| Hôpital d'Instruction des Armées Bégin | Recruiting | Saint-Mandé | France |
|
| Maison de Santé Protestante Bagatelle - Hôpital Bagatelle | Recruiting | Talence | 33404 | France |
|
| CHU de Toulouse - Hôpital Rangueil | Recruiting | Toulouse | France |
|
| CHU de la Martinique | Withdrawn | Fort-de-France | Martinique |
| ID | Term |
|---|---|
| D017719 | Diabetic Foot |
| D003920 | Diabetes Mellitus |
| D014947 | Wounds and Injuries |
| ID | Term |
|---|---|
| D003925 | Diabetic Angiopathies |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D016523 | Foot Ulcer |
| D007871 | Leg Ulcer |
| D012883 | Skin Ulcer |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D048909 | Diabetes Complications |
| D004700 | Endocrine System Diseases |
| D003929 | Diabetic Neuropathies |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided